Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beamtree is an Australian health technology company that provides data-driven solutions and artificial intelligence to improve patient safety and hospital efficiency. The company specializes in clinical decision support, health data auditing, and real-time analytics to reduce clinical risks and optimize healthcare resource allocation. Its core products include RippleDown, which automates expert clinical knowledge for pathology and radiology, and the Ainsoff Deterioration Index, which predicts patient decline in acute care settings. Beamtree serves a global client base including hospitals, diagnostic laboratories, and government health departments across Australia, the UK, and the Middle East. The company is focused on the 'Learning Health System' model, using data to continuously improve clinical outcomes and operational performance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beamtree Holdings.